Genelux Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$2.47

-0.01 (-0.40%)

As of Sep 28, 10:22 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target +117.4% upside

Low Target $3.28

Average Target $5.37

High Target $6.50

Current Price $2.47

Current
$2.47

Target
$5.37

$3.28 $5.37 avg $6.50

Scenario Analysis

Bear Case

$3.28

32.8%

Low target

Base Case

$5.37

+117.4%

Avg target

Bull Case

$6.50

+163.2%

High target

Risk/Reward

5.0x

Highly favorable

Price in Context

52-Week High

$8.54

-71.1% from high

52-Week Low

$2.29

+7.9% from low

Target vs 52W High

$5.37

-37.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%